Feng Deng News Today

Department. Similar to last year, there will be uniformed officers with long guns, undercover officers trained in behavioral observation and officers with k9 s trained to detect explosives. Ed it s difficult to see, but that is 1 28 128. Our biggest delays have been on the mass pike throughout the afternoon. Things are Getting Better all the time, at downtown no troubles at all. Pretty much wideopen, a little bit of volume heading eastbound. Let s go to the maps. Clean and green for the most par...

The University of Pennsylvania, home to the Penn Biden Center, has received contracts and donations from numerous individuals and entities either tied to an elitist Chinese club that landed an alleged off-the-books meeting with then-Vice President Joe Biden in 2011, Hunter Biden's past business deals, or the Chinese Communist Party (CCP), according to a report. 

The University of Pennsylvania, which houses President Biden's think tank, received far more Chinese money than previously known, including from individuals with CCP ties.

Several donors to the University of Pennsylvania have ties to Hunter Biden business deals and some to the Chinese Communist Party (CCP), Fox News reported on Tuesday

VMOV, a startup that develops infrastructure for metaverse, has received a sum of $130 million in its Series B and C rounds.  

Ucello Therapeutics ("Ucello"), a biotechnology company developing universal CAR-T therapies, announced the successful completion of...

SAN DIEGO, Calif. and CHENGDU, China, Feb. 10, 2022 /PRNewswire/ -- Ucello Therapeutics Completes US$25 Million Series A Financing

/PRNewswire/ -- Ucello Therapeutics ("Ucello"), a biotechnology company developing universal CAR-T therapies, announced the successful completion of a US$25...

/PRNewswire/ -- Ucello Therapeutics ("Ucello"), a biotechnology company developing universal CAR-T therapies, announced the successful completion of a US$25...

Teon Therapeutics Completes $30 Million Series A Financing News provided by Share this article Share this article SAN FRANCISCO, Feb. 23, 2021 /PRNewswire/ -- Teon Therapeutics, a biopharmaceutical company developing small molecules that inhibit the immunosuppressive and cancer-promoting signaling pathways, today announced the completion of a $30M Series A financing. The financing was led by Oceanpine Capital with participation from additional new investors Oriza Ventures, Lifespan Investments...